These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


766 related items for PubMed ID: 11600554

  • 1. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
    Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Müller B.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
    [Abstract] [Full Text] [Related]

  • 2. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
    Iqbal A, Jorde R, Figenschau Y.
    J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
    [Abstract] [Full Text] [Related]

  • 3. A Worthy Finding: Decrease in Total Cholesterol and Low-Density Lipoprotein Cholesterol in Treated Mild Subclinical Hypothyroidism.
    Zhao M, Liu L, Wang F, Yuan Z, Zhang X, Xu C, Song Y, Guan Q, Gao L, Shan Z, Zhang H, Zhao J.
    Thyroid; 2016 Aug; 26(8):1019-29. PubMed ID: 27270263
    [Abstract] [Full Text] [Related]

  • 4. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
    Tognini S, Polini A, Pasqualetti G, Ursino S, Caraccio N, Ferdeghini M, Monzani F.
    Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
    [Abstract] [Full Text] [Related]

  • 5. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.
    Ito M, Arishima T, Kudo T, Nishihara E, Ohye H, Kubota S, Fukata S, Amino N, Kuma K, Sasaki I, Hiraiwa T, Hanafusa T, Takamatsu J, Miyauchi A.
    J Clin Endocrinol Metab; 2007 Feb; 92(2):608-11. PubMed ID: 17148561
    [Abstract] [Full Text] [Related]

  • 6. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?
    Efstathiadou Z, Bitsis S, Milionis HJ, Kukuvitis A, Bairaktari ET, Elisaf MS, Tsatsoulis A.
    Eur J Endocrinol; 2001 Dec; 145(6):705-10. PubMed ID: 11720894
    [Abstract] [Full Text] [Related]

  • 7. Prolactin dysregulation in women with subclinical hypothyroidism: effect of levothyroxine replacement therapy.
    Meier C, Christ-Crain M, Guglielmetti M, Huber P, Staub JJ, Müller B.
    Thyroid; 2003 Oct; 13(10):979-85. PubMed ID: 14611708
    [Abstract] [Full Text] [Related]

  • 8. Thyroxine replacement therapy and circulating lipid concentrations.
    Franklyn JA, Daykin J, Betteridge J, Hughes EA, Holder R, Jones SR, Sheppard MC.
    Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
    [Abstract] [Full Text] [Related]

  • 9. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
    Tzotzas T, Krassas GE, Konstantinidis T, Bougoulia M.
    Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
    [Abstract] [Full Text] [Related]

  • 10. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ, Anghelescu N, Endert E, Bakker O, Wiersinga WM.
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. How selective are the new guidelines for treatment of subclinical hypothyroidism for patients with thyrotropin levels at or below 10 mIU/L?
    Rosario PW, Calsolari MR.
    Thyroid; 2013 May; 23(5):562-5. PubMed ID: 23627903
    [Abstract] [Full Text] [Related]

  • 14. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial.
    Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU.
    J Clin Endocrinol Metab; 2007 May; 92(5):1715-23. PubMed ID: 17299073
    [Abstract] [Full Text] [Related]

  • 15. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
    Arinzon Z, Zuta A, Peisakh A, Feldman J, Berner Y.
    Arch Gerontol Geriatr; 2007 May; 44(1):13-9. PubMed ID: 16621071
    [Abstract] [Full Text] [Related]

  • 16. Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children.
    Unal E, Akın A, Yıldırım R, Demir V, Yildiz İ, Haspolat YK.
    J Clin Res Pediatr Endocrinol; 2017 Jun 01; 9(2):144-149. PubMed ID: 28008862
    [Abstract] [Full Text] [Related]

  • 17. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism.
    Müller B, Zulewski H, Huber P, Ratcliffe JG, Staub JJ.
    N Engl J Med; 1995 Oct 12; 333(15):964-9. PubMed ID: 7666915
    [Abstract] [Full Text] [Related]

  • 18. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure.
    Teixeira Pde F, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Buescu A, Costa AJ, Vaisman M.
    Transl Res; 2008 Apr 12; 151(4):224-31. PubMed ID: 18355770
    [Abstract] [Full Text] [Related]

  • 19. Elevated serum lipoprotein(a) in subclinical hypothyroidism.
    Kung AW, Pang RW, Janus ED.
    Clin Endocrinol (Oxf); 1995 Oct 12; 43(4):445-9. PubMed ID: 7586619
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study.
    Caraccio N, Ferrannini E, Monzani F.
    J Clin Endocrinol Metab; 2002 Apr 12; 87(4):1533-8. PubMed ID: 11932277
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 39.